Close Menu

ArtusLabs

PE's most recent catch, the latest in a string of recent informatics purchases, markets the Nexxis electronic laboratory notebook; Nexxis iLAB, a laboratory automation platform; and LimsLink, a lab integration software platform.

"We see informatics as a real opportunity," PerkinElmer CEO Robert Friel said during a conference call to discuss the company's Q1 results. Now the company is mulling how to integrate the three new software firms it acquired over the past two months.

PerkinElmer has completed its acquisition of ArtusLabs and has agreed to purchase CambridgeSoft. The combined purchase price for the two software firms totals $220 million.

The two deals for $220 million in aggregate will expand PerkinElmer's informatics and software offerings and enable customers to access and share enterprise-wide data "for faster, more informed scientific decisions."

News Scan: Feb 27, 2009

Premium

DiscoveryBioMed, ArtusLabs, Heptares Therapeutics, Gentronix, GlaxoSmithKline, BioFocus DPI, Eli Lilly, Millipore, Epitome, ChanTest, Applied Cell Sciences, BioTime, Embryome Sciences, Reproductive Genetics Institute of Chicago, Arizona State University Biodesign Institute, VisionGate

The partnership will use ArtusLabs' web-based platform Ensemble for Life Science as the data-management platform.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.